Connect with us

Technology

Independent Proxy Advisory Firm, ISS, Recommends DDC Shareholders Vote FOR the DDC Transaction Resolution

Published

on

VAUGHAN, ON, Aug. 12, 2024 /CNW/ – Drone Delivery Canada Corp. (“Drone Delivery Canada” or “DDC”) (TSXV: FLT) (OTCQX: TAKOF) (Frankfurt: A3DP5Y) (Frankfurt: ABBA.F), is pleased to announce that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that holders (the “DDC Shareholders”) of common shares in the capital of DDC (“DDC Common Shares”) and variable voting shares in the capital of DDC vote FOR the ordinary resolution (the “DDC Transaction Resolution”) approving the issuance by DDC of up to such number of DDC Common Shares as may be required to be issued in connection with the acquisition by DDC of all of the issued and outstanding common shares in the capital of Volatus Aerospace Corp. (“Volatus”) by way of a proposed plan of arrangement under Section 182 of the Business Corporations Act (Ontario) (the “Transaction”) as contemplated by the business combination agreement between DDC and Volatus dated as of May 20, 2024, as the same may be amended, supplemented or otherwise modified from time to time in accordance with its terms.

Upon closing of the Transaction, DDC and Volatus have agreed that the combined company will continue under the name “Volatus Aerospace Inc.” rather than “Volatus Aerospace Corp. as previously disclosed.

By joining forces, Volatus and DDC plan to immediately begin commercialization efforts, which is intended to enhance shareholder value by forging a robust, financially sound enterprise focused on immediate and long-term revenue with a clear path to sustainable growth and market leadership.

ISS is a leading independent corporate governance analysis and proxy advisory firm that provides proxy voting recommendations to institutional shareholders. The independent recommendation of ISS is intended to assist its shareholder subscribers in making choices regarding proxy voting decisions. ISS made its independent recommendation after carefully reviewing the facts regarding the DDC Transaction Resolution.

“The endorsement from ISS underscores the value and benefits of the proposed Transaction. This recommendation validates our belief that this Transaction is in the best interests of DDC and our stakeholders,” said Steve Magirias, Chief Executive Officer of DDC.

DDC Board Recommendation

The board of directors of DDC unanimously recommends that DDC Shareholders vote FOR the DDC Transaction Resolution.

Full details of the proposed Transaction and voting instructions are set out in the joint management information circular of DDC and Volatus dated July 12, 2024 (the “Information Circular”) and related proxy materials in respect of the annual general and special meeting of DDC Shareholders (the “DDC Meeting”).

The Information Circular, and the form of proxy or voting information form, as applicable, in connection with the Transaction and the DDC Meeting are available on DDC’s website at: https://dronedeliverycanada.com/investors/ and under DDC’s SEDAR+ profile on www.sedarplus.ca.

Vote Today

DDC Shareholders are encouraged to read the Information Circular and vote well in advance of the proxy deadline of 1:00 p.m. (Toronto time) on Thursday, August 15, 2024.

Annual General and Special Meeting Details

DDC will hold the DDC Meeting in-person at the offices of Bennett Jones LLP, 100 King St W Suite 3400, Toronto, ON M5X 1A4 on August 19, 2024 at 1:00 p.m. (Toronto time).

Securityholder Questions and Assistance

DDC Shareholders who have questions or require assistance with voting may contact Carson Proxy, DDC’s proxy solicitation agent:

Carson Proxy

North American Toll-Free Number: 1-800-530-5189

Local and Text: 416-751-2066

Email: info@carsonproxy.com

About DDC

DDC, based in Vaughan, Ontario, is a leader in the drone logistics sector, recognized for its advanced operational capabilities and extensive experience in managing complex drone operations. Having completed more than remotely operated 7,000 flights, the company is expanding its offering to manage the operation of remotely piloted aircraft in both the cargo and drone service sectors globally.

Forward Looking Statements

This news release contains “forward-looking statements” and “forward-looking information” within the meaning of Canadian securities laws, including statements relating to the Transaction, including in respect of the impact of the Transaction and DDC’s expectations regarding the value and benefits of the proposed Transaction. All information that is not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements may be identified by the use of terms such as “forecast”, “projected”, “assumption” and other similar expressions or future or conditional terms such as “anticipate”, “believe”, “could”, “estimate”, “expect”, “intend”, “may”, “plan”, “predict”, “project”, “will”, “would”, and “should”. Forward-looking statements contained in this news release are based on certain factors and assumptions made by management of DDC based on their current expectations, estimates, projections, assumptions and beliefs regarding their business and DDC does not provide any assurance that actual results will meet management’s expectations. While management considers these assumptions to be reasonable based on information currently available to them, they may prove to be incorrect. Such forward-looking statements are not guarantees of future events or performance and by their nature involve known and unknown risks, uncertainties and other factors, including those risks described in the Information Circular and DDC’s management’s discussion and analysis for the year ended December 31, 2023 (both of which are filed under DDC’s SEDAR+ profile on www.sedarplus.ca), that may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward- looking statements. Although DDC has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, other factors may cause actions, events or results to be different than anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate as actual results and future events could vary or differ materially from those anticipated in such forward-looking statements. Accordingly, readers should not place undue reliance on forward-looking information. DDC does not undertake to update any forward-looking information, whether as a result of new information or future events or otherwise, except as may be required by applicable securities laws.

SOURCE Drone Delivery Canada Corp.

Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

on

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Technology

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

Published

on

By

gtinfetch.ai, WeFetch.ai’s lead product, removes the guess from artificial intelligence (AI) shopping: the right barcode, and signed proof of it.

VANCOUVER, BC and LONDON, Nov. 13, 2026 /PRNewswire/ — WeFetch AI Corp., the artificial intelligence (AI) shopping company formerly named GreenCore Solutions Corp., has completed its change of name. The Registrar of Companies for British Columbia issued the Certificate of Change of Name on November 13, 2026.

One Answer for Every Barcode

An AI agent picks a product in words. The same words can match a dozen barcodes: the right brand in the wrong size, last year’s pack, a look-alike from another maker. When the agent guesses, the shopper gets the wrong product, the brand loses a sale it had already won, and the retailer pays for the return.

The Company’s lead product, gtinfetch.ai, removes the guess. It answers for 84,810,515 barcodes from 376,271 makers across 3,520,471 points of sale. An AI agent sends a barcode and gets a firm answer: verified, not verified or unknown, with the sources behind it.

Who it matters to:

The shopper gets the product they asked for.The brand keeps the sale the AI already gave it.The retailer does not pay for a wrong order.

A Signed Receipt of Every Check

When an AI agent buys on a shopper’s behalf, someone has to be able to show it bought the right product. Today nobody can: the agent’s choice leaves no record. gtinfetch.ai gives the agent a signed receipt of the check, written at rco.wefetch.ai and open to public verification. The retailer, the brand and the auditor can each see what was checked, when, and what the answer was. The mark is “Barcode verified”.

Three Regions, One Record

The full record now answers from France, Singapore and the United States. Every barcode also has its own free public page at gtinfetch.ai. The three regions are where AI shopping starts. Singapore has the highest consumer use of generative AI in Asia, at 64.3% of working-age people. France stands at 49.6% and the United States at 33.0%, against 18.8% worldwide. (Source: Microsoft AI Diffusion Report, Q2 2026.) They are also the home markets of the AI that shoppers ask: ChatGPT and Claude in the United States, Mistral in France, and Singapore among the top countries in the world for Claude use per head. (Source: Anthropic Economic Index.)

What we built

WeFetch.ai, the barcode fetch system for AI agents. It answers for 84 million products in 70 countries, with 3.5 million points of sale on its own record, and includes:

triggerfetch for brands;shopfetch for shoppers;matchfetch for AI agents;gtinfetch, the record itself.

It is AI native, and works with ChatGPT, Claude, Gemini, Grok, Mistral, Perplexity and Muse. Every answer is signed.

“Words were the first generation of AI answers. Barcodes are agentic commerce,” said Matthew Keddy, Chief Executive Officer of WeFetch AI Corp. “Every AI agent that moves from search results to shopping needs barcode precision. wefetch has it, signed, in three regions.”

The market: Gartner forecasts $2.7 trillion in AI spending in 2026. McKinsey projects that AI agents will orchestrate $3 trillion to $5 trillion in global commerce by 2030, up to $1 trillion of it in US retail. Every one of those AI agent purchases needs the right barcode.

About WeFetch AI Corp.

WeFetch AI Corp. develops AI software products for AI shopping, retail, grocery and fast-moving consumer goods (FMCG). Its lead product, gtinfetch.ai, is the AI agentic shopping barcode engine: 84 million barcodes, answered for the agents of seven AI labs. WeFetch is headquartered in Vancouver, Canada, with sales offices in London, UK. Please visit: wefetch.ai

View original content:https://www.prnewswire.com/news-releases/wefetch-ai-corp-is-the-new-name-of-greencore-solutions-corp-302939459.html

SOURCE Greencore Solutions Corp.

Continue Reading

Technology

/C O R R E C T I O N – BTQ Technologies Corp./

Published

on

By

In the news release, BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update, issued Nov. 13, 2026 by BTQ Technologies Corp. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows:

BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update

VANCOUVER, BC, Nov. 13, 2026 /PRNewswire/ — BTQ Technologies Corp. (“BTQ” or the “Company”) (Nasdaq: BTQ) (CBOE CA: BTQ),  a global technology company building the trust infrastructure for the quantum era, is pleased to announce that it will hold a shareholder call on Friday, November 17, 2026, at 11:00 a.m. EST to discuss its quarterly financial results and provide a general corporate update. The call will follow the release of the Company’s Q3 2026 financial statements, which will be issued after market close on Monday, November 16, 2026.

IMPORTANT – To register for the webcast see below:

When: November 17, 2026
Time: 11:00 AM Eastern Time
Topic: BTQ Technologies Shareholder Call to Discuss Q3 2026 Financial Results and Corporate Update

Register in advance for this webinar:
https://us06web.zoom.us/webinar/register/WN_n6WGI3lERpCZcA63pWQWVQ 

After registering, you will receive a confirmation email containing information about joining the webinar.

About BTQ
BTQ Technologies Corp. (Nasdaq: BTQ | Cboe CA: BTQ) is a quantum technology company focused on accelerating the transition from classical networks to the quantum internet. Backed by a broad patent portfolio and deep technical expertise, BTQ is developing a full-stack, neutral-atom quantum computing platform spanning hardware, middleware, and post-quantum security solutions for finance, telecommunications, logistics, life sciences, and defense.

Connect with BTQ: Website | LinkedIn | X/Twitter

ON BEHALF OF THE BOARD OF DIRECTORS
Olivier Roussy Newton
CEO, Chairman

Neither Cboe Canada nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Information

Certain statements herein contain forward-looking statements and forward-looking information within the meaning of applicable securities laws. Such forward-looking statements or information include but are not limited to statements or information with respect to the business plans of the Company, including with respect to its research partnerships, and anticipated markets in which the Company may be listing its common shares. Forward-looking statements or information often can be identified by the use of words such as “anticipate”, “intend”, “expect”, “plan” or “may” and the variations of these words are intended to identify forward-looking statements and information.

The Company has made numerous assumptions including among other things, assumptions about general business and economic conditions, the development of post-quantum algorithms and quantum vulnerabilities, and the quantum computing industry generally. The foregoing list of assumptions is not exhaustive.

Although management of the Company believes that the assumptions made and the expectations represented by such statements or information are reasonable, there can be no assurance that forward-looking statements or information herein will prove to be accurate. Forward-looking statements and information are based on assumptions and involve known and unknown risks which may cause actual results to be materially different from any future results, expressed or implied, by such forward-looking statements or information. These factors include risks relating to: the availability of financing for the Company; business and economic conditions in the post-quantum and encryption computing industries generally; the speculative nature of the Company’s research and development programs; the supply and demand for labour and technological post-quantum and encryption technology; unanticipated events related to regulatory and licensing matters and environmental matters; changes in general economic conditions or conditions in the financial markets; changes in laws (including regulations respecting blockchains); risks related to the direct and indirect impact of COVID-19 including, but not limited to, its impact on general economic conditions, the ability to obtain financing as required, and causing potential delays to research and development activities; and other risk factors as detailed from time to time. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

Correction: An earlier version of this release incorrectly [describe the update briefly].

View original content to download multimedia:https://www.prnewswire.com/news-releases/btq-technologies-to-host-live-webinar-on-q3-2026-financial-results-and-general-corporate-update-302939440.html

SOURCE BTQ Technologies Corp.

Continue Reading

Trending